FDA expands AVTOZMA IV approval to include cytokine release syndrome

7th August 2025 Uncategorised 0

Celltrion’s biosimilar now fully aligned with ACTEMRA IV indications in US

More: FDA expands AVTOZMA IV approval to include cytokine release syndrome
Source: News